Zacks Research Brokers Lift Earnings Estimates for McKesson

McKesson Co. (NYSE:MCK) – Research analysts at Zacks Research raised their Q3 2025 earnings per share (EPS) estimates for shares of McKesson in a research report issued on Wednesday, November 27th. Zacks Research analyst R. Department now forecasts that the company will post earnings of $8.30 per share for the quarter, up from their previous forecast of $8.24. The consensus estimate for McKesson’s current full-year earnings is $32.73 per share. Zacks Research also issued estimates for McKesson’s Q4 2025 earnings at $9.17 EPS, FY2025 earnings at $32.43 EPS, Q1 2026 earnings at $7.92 EPS, Q3 2026 earnings at $10.02 EPS and Q4 2026 earnings at $8.99 EPS.

McKesson (NYSE:MCK) last released its quarterly earnings data on Wednesday, November 6th. The company reported $7.07 earnings per share for the quarter, beating the consensus estimate of $6.88 by $0.19. McKesson had a negative return on equity of 207.50% and a net margin of 0.77%. The business had revenue of $93.65 billion for the quarter, compared to analysts’ expectations of $89.33 billion. During the same quarter in the previous year, the business posted $6.23 EPS. McKesson’s revenue for the quarter was up 21.3% on a year-over-year basis.

MCK has been the topic of several other research reports. Wells Fargo & Company cut their target price on McKesson from $576.00 to $535.00 and set an “equal weight” rating on the stock in a research note on Friday, September 13th. Evercore ISI boosted their target price on McKesson from $560.00 to $680.00 and gave the company an “outperform” rating in a research note on Thursday, November 7th. Baird R W upgraded McKesson from a “hold” rating to a “strong-buy” rating in a research note on Thursday, November 7th. Citigroup boosted their target price on McKesson from $630.00 to $713.00 and gave the company a “buy” rating in a research note on Wednesday, November 13th. Finally, Mizuho boosted their target price on McKesson from $540.00 to $570.00 and gave the company a “neutral” rating in a research note on Thursday, August 8th. Two analysts have rated the stock with a hold rating, fourteen have given a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $631.57.

McKesson Price Performance

NYSE:MCK opened at $617.98 on Monday. McKesson has a fifty-two week low of $431.35 and a fifty-two week high of $637.51. The stock has a market capitalization of $78.45 billion, a PE ratio of 32.00, a price-to-earnings-growth ratio of 1.34 and a beta of 0.49. The business’s 50-day simple moving average is $547.30 and its 200-day simple moving average is $560.86.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Wolff Wiese Magana LLC grew its holdings in McKesson by 742.9% in the 3rd quarter. Wolff Wiese Magana LLC now owns 59 shares of the company’s stock valued at $29,000 after buying an additional 52 shares in the last quarter. MidAtlantic Capital Management Inc. acquired a new stake in shares of McKesson during the 3rd quarter worth $29,000. RPg Family Wealth Advisory LLC acquired a new stake in shares of McKesson during the 3rd quarter worth $31,000. ORG Wealth Partners LLC acquired a new stake in shares of McKesson during the 3rd quarter worth $40,000. Finally, Carmichael Hill & Associates Inc. acquired a new stake in shares of McKesson during the 2nd quarter worth $52,000. 85.07% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling

In other McKesson news, CEO Brian S. Tyler sold 3,753 shares of the company’s stock in a transaction on Thursday, September 5th. The stock was sold at an average price of $561.10, for a total value of $2,105,808.30. Following the transaction, the chief executive officer now directly owns 78,586 shares of the company’s stock, valued at $44,094,604.60. This represents a 4.56 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. 0.11% of the stock is owned by insiders.

McKesson Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Thursday, January 2nd. Investors of record on Monday, December 2nd will be issued a dividend of $0.71 per share. This represents a $2.84 dividend on an annualized basis and a dividend yield of 0.46%. The ex-dividend date is Monday, December 2nd. McKesson’s payout ratio is presently 14.71%.

McKesson Company Profile

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.